Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Small peptide inhibitor of PKC gamma shows activity in neuropathic pain models

Nov. 21, 2007

KCNQ2/3 channel opener from ICAgen shows activity in pain in vivo models

Nov. 21, 2007

Taisho reports on novel antagonists of the MCH receptor 1

Nov. 20, 2007

Novel small-molecule compound appears to extend L-DOPA antiparkinsonian effects

Nov. 19, 2007

FDA approves Seroquel XR for maintenance treatment of schizophrenia

Nov. 19, 2007

Ceregene completes enrollment in phase II clinical trial of CERE-120 for Parkinson's disease

Nov. 19, 2007

New agents for treating neurological disorders disclosed in recent patent literature

Nov. 19, 2007

Neuroprotection by small-molecule Hedgehog agonist in an in vitro model of ischemia

Nov. 19, 2007

Preclinical profile of Merck & Co.'s novel NR2B-selective NMDA antagonist

Nov. 19, 2007

FDA grants priority review to Abilify sNDA for treatment of bipolar pediatric patients

Nov. 16, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...